My Quote Request
No products added yet
6505-01-234-2897
20 Products
NDC00005-3050-23
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012342897
NSN
6505-01-234-2897
NDC00005-3050-23
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012342897
NSN
6505-01-234-2897
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COMPRESSED TABLET
THERAPEUTIC EQUIVALENT: NOT LISTED
Related Searches:
80-B2
AMINOPHYLLINE INJECTION,USP
NSN, MFG P/N
6505012337849
NSN
6505-01-233-7849
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 19.7MG. THEOPHYLLINE PER ML. (EQUIVALENT TO AMINOPHYLLINE ANHYDROUS 25 MG. PER ML.)
ADMINISTRATION: INTRAVENOUS
III THERAPEUTIC EQUIVALENT: RATED AP
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC00469-8002-00
AMINOPHYLLINE INJECTION,USP
NSN, MFG P/N
6505012337849
NSN
6505-01-233-7849
NDC00469-8002-00
AMINOPHYLLINE INJECTION,USP
NSN, MFG P/N
6505012337849
NSN
6505-01-233-7849
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 19.7MG. THEOPHYLLINE PER ML. (EQUIVALENT TO AMINOPHYLLINE ANHYDROUS 25 MG. PER ML.)
ADMINISTRATION: INTRAVENOUS
III THERAPEUTIC EQUIVALENT: RATED AP
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
AK-CIDE
SULFACETAMIDE SODIUM AND PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505012337850
NSN
6505-01-233-7850
AK-CIDE
SULFACETAMIDE SODIUM AND PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505012337850
NSN
6505-01-233-7850
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS SULFACETAMIDE SODIUM PER MILLILITER AND 5.000 MILLIGRAMS PREDNISOLONE ACETATE PER MILLILITER
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: NOT RATED
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC17478-0275-12
SULFACETAMIDE SODIUM AND PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505012337850
NSN
6505-01-233-7850
NDC17478-0275-12
SULFACETAMIDE SODIUM AND PREDNISOLONE ACETATE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505012337850
NSN
6505-01-233-7850
MFG
AKORN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS SULFACETAMIDE SODIUM PER MILLILITER AND 5.000 MILLIGRAMS PREDNISOLONE ACETATE PER MILLILITER
ADMINISTRATION: ORAL
FEATURES PROVIDED: STERILE
III THERAPEUTIC EQUIVALENT: NOT RATED
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH DROPPER, PLASTIC SQUEEZE
Related Searches:
NDC00364-0483-05
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505012340216
NSN
6505-01-234-0216
NDC00364-0483-05
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505012340216
NSN
6505-01-234-0216
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: SOFT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:GELATIN
Related Searches:
323-2107
AMINO ACID INJECTION
NSN, MFG P/N
6505012341530
NSN
6505-01-234-1530
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.2 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
HEPATAMINE
AMINO ACID INJECTION
NSN, MFG P/N
6505012341530
NSN
6505-01-234-1530
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.2 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
HEPATAMINE 8%
AMINO ACID INJECTION
NSN, MFG P/N
6505012341530
NSN
6505-01-234-1530
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.2 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00264-9371-55
AMINO ACID INJECTION
NSN, MFG P/N
6505012341530
NSN
6505-01-234-1530
NDC00264-9371-55
AMINO ACID INJECTION
NSN, MFG P/N
6505012341530
NSN
6505-01-234-1530
MFG
COLGATE-PALMOLIVE CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.2 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
S9371
AMINO ACID INJECTION
NSN, MFG P/N
6505012341530
NSN
6505-01-234-1530
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 8.000 PERCENTAGE, W/V AMINO ACIDS ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH HANGING DEVICE, GLASS
SPECIAL FEATURES: NON-PYROGENIC; CONTAINS 1.2 GRAMS OF NITROGEN PER 100 ML; STOPPER SHALL ACCEPT AND RETAIN THE PIERCING DEVICE OF THE STOCKLISTED INTRAVENOUS SETS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
3362
METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012342217
NSN
6505-01-234-2217
3362
METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012342217
NSN
6505-01-234-2217
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
ALDORIL TABLETS
METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012342217
NSN
6505-01-234-2217
ALDORIL TABLETS
METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012342217
NSN
6505-01-234-2217
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00006-0694-68
METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012342217
NSN
6505-01-234-2217
NDC00006-0694-68
METHYLDOPA AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012342217
NSN
6505-01-234-2217
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 500.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
DYMELOR
ACETOHEXAMIDE TABLETS,USP
NSN, MFG P/N
6505012342218
NSN
6505-01-234-2218
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ACETOHEXAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LILLY
THERAPEUTIC EQUIVALENT: NOT RATED
Related Searches:
DYMELOR TABLETS
ACETOHEXAMIDE TABLETS,USP
NSN, MFG P/N
6505012342218
NSN
6505-01-234-2218
DYMELOR TABLETS
ACETOHEXAMIDE TABLETS,USP
NSN, MFG P/N
6505012342218
NSN
6505-01-234-2218
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ACETOHEXAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LILLY
THERAPEUTIC EQUIVALENT: NOT RATED
Related Searches:
NDC00002-2103-03
ACETOHEXAMIDE TABLETS,USP
NSN, MFG P/N
6505012342218
NSN
6505-01-234-2218
NDC00002-2103-03
ACETOHEXAMIDE TABLETS,USP
NSN, MFG P/N
6505012342218
NSN
6505-01-234-2218
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ACETOHEXAMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,LILLY
THERAPEUTIC EQUIVALENT: NOT RATED
Related Searches:
967-30
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012342219
NSN
6505-01-234-2219
967-30
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012342219
NSN
6505-01-234-2219
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
EXPIRATION DATING PERIOD IN MONTHS: 24
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE DOSE VIAL; PH ADJUSTED WITH HYDROCHLORIC ACID IF NECESSARY
STABILIZER: PRESERVATIVE AGENT
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
TOTAL PRIMARY CONTAINER QUANTITY: 25
UNIT PACKAGE TYPE: BOX
WARNING AND CAUTION STATEMENTS: WARNING: MUST BE DILUTED PRIOR TOADMINISTRATION
Related Searches:
NDC00467-0067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012342219
NSN
6505-01-234-2219
NDC00467-0067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505012342219
NSN
6505-01-234-2219
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
EXPIRATION DATING PERIOD IN MONTHS: 24
FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: MULTIPLE DOSE VIAL; PH ADJUSTED WITH HYDROCHLORIC ACID IF NECESSARY
STABILIZER: PRESERVATIVE AGENT
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
TOTAL PRIMARY CONTAINER QUANTITY: 25
UNIT PACKAGE TYPE: BOX
WARNING AND CAUTION STATEMENTS: WARNING: MUST BE DILUTED PRIOR TOADMINISTRATION
Related Searches:
NDC00005-3051-34
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012342896
NSN
6505-01-234-2896
NDC00005-3051-34
BENZTROPINE MESYLATE TABLETS,USP
NSN, MFG P/N
6505012342896
NSN
6505-01-234-2896
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BENZTROPINE MESYLATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COMPRESSED TABLET
THERAPEUTIC EQUIVALENT: NOT LISTED
